Skip to main content
GAMN
OTC Life Sciences

Great American Food Chain Completes Merger with GreenMatter Biotech, Appoints New CEO

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.05
Mkt Cap
$382.3K
52W Low
$0.005
52W High
$0.15
52W Position info
863% above low
Off High info
67% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

GAMN has more than doubled off its 52-week low of $0.005 on light trading volume (0.2× avg).

Summary

Great American Food Chain (GAMN) has officially completed its merger with GreenMatter Biotech. Concurrently, Joe H. Wicker Jr. has been appointed as the new Chief Executive Officer of the combined entity. This completed merger represents a highly significant corporate action for the OTC-listed company, fundamentally altering its business scope and strategic direction. The integration with a biotech firm suggests a material shift or expansion into areas such as food science, sustainable technologies, or other life sciences applications. Traders should closely monitor the integration process and any subsequent announcements regarding the combined company's operational strategy and financial outlook.

At the time of this announcement, GAMN was trading at $0.05 on OTC in the Life Sciences sector, with a market capitalization of approximately $382.3K. The 52-week trading range was $0.01 to $0.15. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GAMN - Latest Insights